Curis Inc

NASDAQ: CRIS
$14.77
-$0.24 (-1.6%)
Closing price April 24, 2024
Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. The company is headquartered in Lexington, Massachusetts.

Top Analyst Upgrades and Downgrades: AMD, Cisco, eHealth, iHeart Media, Intel, Playtika, ViacomCBS, Williams-Sonoma and More
Thursday's top analyst upgrades and downgrades included AllianceBernstein, AMD, Cisco, eHealth, iHeart Media, Intel, Playtika, ViacomCBS and Williams-Sonoma.
Lee Jackson
Published:
Last Updated:

The Hits Keep Coming With Curis's Secondary Offering
Curis shares are on the run again. This time it’s due to a secondary offering.
Chris Lange
Published:

This Curis Cancer Study Is a Big Hit
Curis has announced preliminary data from its ongoing early-stage study in patients with acute myeloid leukemia or high-risk myelodysplastic syndromes.
Chris Lange
Published: